Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 18 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Raises More Than $42 Million, Completes Sarfartoq Field Program
Greenland Mines (NASDAQ: GRML) raised more than $42 million from existing investors through a registered…
-
QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in AINewsWire Editorial on Natural Hydrogen, AI Energy Demand
This article has been disseminated on behalf of MAX Power Mining and may include paid…
-
QualityStocksNewsBreaks – Frontieras North America Selects Kiewit for FEED of Mason County Facility
Frontieras North America announced that it selected Kiewit Engineering Group Inc., a subsidiary of Kiewit…